Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
114.23
+1.81 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
Abbott Laboratories Employees
Abbott Laboratories had 114,000 employees as of December 31, 2023. The number of employees decreased by 1,000 or -0.87% compared to the previous year.
Employees
114,000
Change (1Y)
-1,000
Growth (1Y)
-0.87%
Revenue / Employee
$361,553
Profits / Employee
$50,386
Market Cap
198.13B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
Dec 31, 2012 | 91,000 | 0 | - |
Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
Dec 31, 2005 | 59,735 | -865 | -1.43% |
Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
Dec 31, 2003 | 72,200 | 381 | 0.53% |
Dec 31, 2002 | 71,819 | 393 | 0.55% |
Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
Dec 31, 1999 | 57,100 | 864 | 1.54% |
Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
Dec 31, 1995 | 50,241 | 777 | 1.57% |
Dec 31, 1994 | 49,464 | -195 | -0.39% |
Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Pfizer | 88,000 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Danaher | 63,000 |
AbbVie | 50,000 |
Amgen | 26,700 |
ABT News
- 17 hours ago - Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline - Seeking Alpha
- 4 days ago - Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart - PRNewsWire
- 7 days ago - Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value - Seeking Alpha
- 8 days ago - Abbott Increases Quarterly Dividend for 53rd Consecutive Year - PRNewsWire
- 14 days ago - University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott - PRNewsWire
- 25 days ago - The Best Large-Cap Stocks to Buy - Kiplinger
- 26 days ago - Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis - PRNewsWire
- 26 days ago - Abbott Laboratories: Investors Should Wait For A Pullback - Seeking Alpha